Choice of antipsychotics in Australia often suboptimum, psychiatrists say
A study of five years of medicines data provides a snapshot of prescribing practice
People with schizophrenia have the best medication adherence with clozapine or second-generation long-acting injectable antipsychotics yet only a quarter of eligible patients are on them, PBS data show.
The study shows persistence with therapy varies widely and suggests earlier initiation of these agents may improve patient prognosis, the authors say.
The researchers, led by consultant psychiatrist Associate Professor Mark Taylor, from the University of Queensland,
